Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 18

1.

Delineating transcriptional networks of prognostic gene signatures refines treatment recommendations for lymph node-negative breast cancer patients.

Lanigan F, Brien GL, Fan Y, Madden SF, Jerman E, Maratha A, Aloraifi F, Hokamp K, Dunne EJ, Lohan AJ, Flanagan L, Garbe JC, Stampfer MR, Fridberg M, Jirstrom K, Quinn CM, Loftus B, Gallagher WM, Geraghty J, Bracken AP.

FEBS J. 2015 Sep;282(18):3455-73. doi: 10.1111/febs.13354. Epub 2015 Jul 14.

PMID:
26094870
2.

Peripheral selectivity of the novel cannabinoid receptor antagonist TM38837 in healthy subjects.

Klumpers LE, Fridberg M, de Kam ML, Little PB, Jensen NO, Kleinloog HD, Elling CE, van Gerven JM.

Br J Clin Pharmacol. 2013 Dec;76(6):846-57. doi: 10.1111/bcp.12141.

3.

Locking plate osteosynthesis of clavicle fractures: complication and reoperation rates in one hundred and five consecutive cases.

Fridberg M, Ban I, Issa Z, Krasheninnikoff M, Troelsen A.

Int Orthop. 2013 Apr;37(4):689-92. doi: 10.1007/s00264-013-1793-9. Epub 2013 Feb 3.

4.

High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma.

Nodin B, Fridberg M, Jonsson L, Bergman J, Uhlén M, Jirström K.

Diagn Pathol. 2012 Jul 17;7:82. doi: 10.1186/1746-1596-7-82.

5.

Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer.

Larsson A, Fridberg M, Gaber A, Nodin B, Levéen P, Jönsson G, Uhlén M, Birgisson H, Jirström K.

BMC Cancer. 2012 Jul 8;12:282. doi: 10.1186/1471-2407-12-282.

6.

Modifying effect of gender on the prognostic value of clinicopathological factors and Ki67 expression in melanoma: a population-based cohort study.

Fridberg M, Jonsson L, Bergman J, Nodin B, Jirström K.

Biol Sex Differ. 2012 Jul 2;3(1):16. doi: 10.1186/2042-6410-3-16.

7.

Discovery of dachshund 2 protein as a novel biomarker of poor prognosis in epithelial ovarian cancer.

Nodin B, Fridberg M, Uhlén M, Jirström K.

J Ovarian Res. 2012 Jan 27;5(1):6. doi: 10.1186/1757-2215-5-6.

8.

Immunohistochemical analyses of phosphatases in childhood B-cell lymphoma: lower expression of PTEN and HePTP and higher number of positive cells for nuclear SHP2 in B-cell lymphoma cases compared to controls.

Fridberg M, Kjellström S, Anagnostaki L, Skogvall I, Mustelin T, Wiebe T, Persson JL, Dictor M, Wingren AG.

Pediatr Hematol Oncol. 2008 Sep;25(6):528-40. doi: 10.1080/08880010802237054.

PMID:
18728972
9.

Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: higher expression of ZAP70 and PKC-beta II in the non-germinal center group and poor survival in patients deficient in nuclear PTEN.

Fridberg M, Servin A, Anagnostaki L, Linderoth J, Berglund M, Söderberg O, Enblad G, Rosén A, Mustelin T, Jerkeman M, Persson JL, Wingren AG.

Leuk Lymphoma. 2007 Nov;48(11):2221-32.

PMID:
17926183
10.

Establishment of a cell line from a chemotherapy resistant diffuse large B-cell lymphoma.

Berglund M, Thunberg U, Fridberg M, Wingren AG, Gullbo J, Leuchowius KJ, Amini RM, Lagercrantz S, Horvat A, Enblad G, Söderberg O.

Leuk Lymphoma. 2007 May;48(5):1038-41. No abstract available.

PMID:
17487752
11.

Abdominal strength after breast reconstruction using a free abdominal flap.

Bonde CT, Lund H, Fridberg M, Danneskiold-Samsoe B, Elberg JJ.

J Plast Reconstr Aesthet Surg. 2007;60(5):519-23. Epub 2007 Jan 17.

PMID:
17399661
12.

A study of the pharmacokinetics and safety of recombinant activated factor VII in healthy Caucasian and Japanese subjects.

Fridberg MJ, Hedner U, Roberts HR, Erhardtsen E.

Blood Coagul Fibrinolysis. 2005 Jun;16(4):259-66.

PMID:
15870545
13.

Recombinant coagulation factor VIIa in major liver resection: a randomized, placebo-controlled, double-blind clinical trial.

Lodge JP, Jonas S, Oussoultzoglou E, Malagó M, Jayr C, Cherqui D, Anthuber M, Mirza DF, Kuhlman L, Bechstein WO, Díaz JC, Tartiere J, Eyraud D, Fridberg M, Erhardtsen E, Mimoz O.

Anesthesiology. 2005 Feb;102(2):269-75.

PMID:
15681939
14.

Studies of genetic variability of the uncoupling protein 1 gene in Caucasian subjects with juvenile-onset obesity.

Urhammer SA, Fridberg M, Sørensen TI, Echwald SM, Andersen T, Tybjaerg-Hansen A, Clausen JO, Pedersen O.

J Clin Endocrinol Metab. 1997 Dec;82(12):4069-74.

PMID:
9398715
15.
16.

Genetic variation in the hepatocyte nuclear factor-1 alpha gene in Danish Caucasians with late-onset NIDDM.

Urhammer SA, Rasmussen SK, Kaisaki PJ, Oda N, Yamagata K, Møller AM, Fridberg M, Hansen L, Hansen T, Bell GI, Pedersen O.

Diabetologia. 1997 Apr;40(4):473-5.

PMID:
9112026
17.

Novel MODY3 mutations in the hepatocyte nuclear factor-1alpha gene: evidence for a hyperexcitability of pancreatic beta-cells to intravenous secretagogues in a glucose-tolerant carrier of a P447L mutation.

Hansen T, Eiberg H, Rouard M, Vaxillaire M, Møller AM, Rasmussen SK, Fridberg M, Urhammer SA, Holst JJ, Almind K, Echwald SM, Hansen L, Bell GI, Pedersen O.

Diabetes. 1997 Apr;46(4):726-30.

PMID:
9075819
18.

[Disopyramide and lignocaine in the treatment of ventricular arrhythmia in patients with acute ischemic heart disease].

Pedersen-Bjergaard O, Lindeneg O, Svendsen TL, Enk B, Fridberg M.

Ugeskr Laeger. 1986 May 26;148(22):1349-51. Danish. No abstract available.

PMID:
3523916
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk